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Abstract The membrane-interacting domain that precedes the
transmembrane anchor of Ebola glycoprotein has been charac-
terized. This aromatic-rich region is predicted to bind the mem-
brane interface adopting an K-helical structure. Peptides repre-
senting either the Ebola glycoprotein pre-transmembrane
sequence, or a ‘scrambled’ control with a di¡erent hydropho-
bic-at-interface moment, have been studied. Insertion into lipid
monolayers, changes in intrinsic £uorescence and in infrared
spectra demonstrated that only the wild-type peptide bound
the interface under equilibrium conditions and adopted an
K-helical conformation. The presence of the raft-associated lipid
sphingomyelin did not a¡ect membrane insertion, but it stimu-
lated highly the membrane-destabilizing capacity of the pre-
transmembrane sequence. A parallel study of the e¡ects of the
viral sequence and of melittin suggests that Ebola glycoprotein
pre-transmembrane sequence might target membranes inher-
ently prone to destabilization by lytic peptides.
$ 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Ebola virus glycoprotein (GP) is responsible for both recep-
tor binding and membrane fusion during viral entry into the
host cells [1,2]. This glycoprotein is synthesized as a precursor
molecule and subsequently cleaved by furin into two disul¢de-
linked subunits, surface (GP1) and transmembrane (GP2)
[1,2]. The crystal structure of GP2 ectodomain has been de-
termined and consists of a trimeric helical bundle whose core
is organized as a triple-stranded coiled-coil [3,4]. The coiled-
coil structure plays an important role in facilitating the entry
of Ebola virus into host cells [5]. It has been recently demon-
strated that GP associates with lipid rafts after synthesis, sug-
gesting that Ebola might assemble and emerge through these
distinct lipid microdomains [6]. In the same work, evidence is
also provided in support of the idea that rafts play a critical
role at the entry stage of Ebola infection.
Mutagenesis and biophysical characterization con¢rmed
earlier predictions indicating the existence in GP2 of an inter-
nal fusion peptide consisting of approximately 16 uncharged
hydrophobic residues [7^9]. Ebola GP also contains within the
membrane-proximal region of the GP2 ectodomain a second
sequence showing a high tendency to partition into membrane
interfaces [10,11]. Computation of the hydrophobic-at-inter-
face moment for this element re£ects a tendency to segregate
interfacial residues into a de¢ned surface of an K-helix, sug-
gesting that the GP2 pre-transmembrane sequence (preTM)
might partition into membranes adopting a helical structure.
Experimental work demonstrated that the sequence ful¢lls the
predictions of the Wimley^White [12] algorithms, namely
spontaneous partitioning into membrane interfaces and an
K-helix representing the main conformation of the soluble
and membrane-inserted forms. Disturbance of the helical mo-
ment by scrambling the sequence interfered with its ability to
fold in solution and in membranes adopting a helical struc-
ture, as well as with the partitioning equilibrium. Wild-type
Ebola pre-TM, but not scrambled Ebola pre-TM, breached
the permeability barrier of membranes. Of note, permeabili-
zation was promoted in the presence of sphingomyelin (SM),
a raft-associated lipid. Our results sustain the notion that the
aromatic-rich pre-transmembrane domain in Ebola glycopro-
tein may interact monotopically with membranes as an K-he-
lix and promote perturbations therein. The ¢ndings in this
work may help in understanding the molecular mechanism
by which Ebola GP2 induces membrane merging.
2. Materials and methods
Cholesterol (CHOL), egg phosphatidylcholine (PC), egg phosphati-
dylethanolamine (PE), and brain SM were purchased from Avanti
Polar Lipids (Birmingham, AL, USA). 8-Aminonaphthalene-1,3,6-tri-
sulfonic acid sodium salt (ANTS) and p-xylenebis(pyridinium)bro-
mide (DPX) were from Molecular Probes (Junction City, OR,
USA). D2O, N-acetyl-L-tryptophanamide and Triton X-100 were ob-
tained from Sigma (St. Louis, MO, USA). All other reagents were of
analytical grade. The sequences representing the pre-transmembrane
stretch of Ebola GP2 (residues 640^657 of Ebola GP precursor, Zaire
strain, GenBank U31033), DNDNWWTGWRQWIPAGIG (EBOc)
and its scrambled variant DWGDAPNWRWNWGIIGTQ (EBOscr)
were synthesized as C-terminal carboxamides and puri¢ed (estimated
homogeneity s 90%) by Neosystem (Strasbourg, France). Synthetic
melittin was obtained from Bachem (Bubendorf, Switzerland). Peptide
stock solutions were prepared in dimethylsulfoxide (spectroscopy
grade).
To compute the hydrophobic-at-interface moment, we considered
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the membrane interface-to-water transfer free energies (vGiwu) for
each amino acid [12] as the moduli of the vectors that project from
the main axes of the secondary structure element, following the direc-
tion of the amino acid side chains [13]. The hydrophobic moment (WH)
of a sequence of N residues was then calculated as the addition of the
N hydrophobicity vectors corresponding to the constituent amino
acids, following the equation [13,14]:
WH ¼
XN
n¼1
Hn sinðN nÞ
 !2
þ
XN
n¼1
Hn cosðN nÞ
 !20@
1
A
1=2
where Hn is the hydrophobicity of the n residue, and N is the angle
formed between side chains of consecutive residues, i.e. 100‡ for he-
lical conformations.
Large unilamellar vesicles (LUV) were prepared according to the
extrusion method of Hope et al. [15] in 5 mM HEPES, 100 mM NaCl
(pH 7.4). When required, osmolalities were adjusted to 200 mOsm in a
cryoscopic osmometer (Osmomat 030, Gonotec, Berlin, Germany).
Lipid concentrations of liposome suspensions were determined by
phosphate analysis [16]. The average diameter of vesicles was ca.
100 nm according to quasi-elastic light scattering determinations using
a Malvern Zeta-Sizer instrument.
For assays of monolayer penetration [17] surface pressure was de-
termined in a ¢xed-area circular through (WTrough S system, Kibron,
Helsinki, Finland). Measurements were carried out at room temper-
ature and under constant stirring. The aqueous phase consisted of 1 ml
5 mM HEPES, 100 mM NaCl (pH 7.4). Lipids, dissolved in chloro-
form, were spread over the surface and the desired initial surface
pressure (Z0) was attained by changing the amount of lipid applied
to the air^water interface. Peptide was injected into the subphase with
a Hamilton microsyringe. At the concentrations used the peptide
alone induced a negligible increase in surface pressure at the air^water
interface.
Peptide insertion into bilayers was subsequently evaluated by mon-
itoring the change in emitted Trp-£uorescence upon partitioning into
LUV [18]. Corrected spectra were obtained in a Perkin Elmer MPF-66
spectro£uorimeter with the excitation set at 280 nm and 5-nm slits. In
selected instances partitioning curves were subsequently computed
from the fractional change in emitted Trp-£uorescence when titrated
with increasing lipid concentrations, as described in [18].
Release of vesicular contents or leakage to the medium was moni-
tored by the ANTS/DPX assay [19]. The procedure is described in
detail in [20]. All these £uorescence measurements were conducted in
thermostatically controlled cuvettes (25‡C). The medium in the cu-
vettes was continuously stirred to allow the rapid mixing of peptide
and vesicles.
Infrared spectroscopy (IR) measurements were conducted essen-
tially as in [20]. Samples in the presence of vesicles consisted of £oated
peptide^lipid complexes obtained in D2O bu¡er after ultracentrifuga-
tion. Solvent samples were also obtained from the supernatant frac-
tion not containing lipid or peptide and subsequently used as back-
ground controls. Infrared spectra were recorded in a Nicolet 520
spectrometer equipped with an MCT detector. Samples were placed
between two CaF2 windows separated by 50-Wm spacers. 1000 scans
(sample) and 1000 scans (reference) were taken for each spectrum,
using a shuttle device. Subtraction and band position determination
were performed according to procedures described in [21] with the
help of OMNIC and Grams softwares.
3. Results and discussion
3.1. Description of Ebola GP pre-transmembrane as an
interfacial sequence
Fig. 1A shows the membrane-partitioning sequences within
Ebola GP. The plot in this ¢gure is based on the hydropho-
bicity-at-interface scale as determined by Wimley and White
[12]. The sequence at the N-terminus of the GP1 subunit, SP,
corresponds to the signal peptide. The internal fusion peptide
FP is located close to the GP2 N-terminus. This stretch com-
prises approximately residues 524GAAIGLAWIPYFGPA-
A539 [7^9]. An additional conspicuous region (marked preTM
in Fig. 1A) showing a⁄nity for membrane interfaces spans
approximately residues 640DNDNWWTGWRQWIPAGIG-
657, preceding the C-terminal hydrophobic 658^676 trans-
membrane (TMD) anchor. Apart from FP, preTM and TMD,
no other relevant membrane-interacting regions are found
in the mature Ebola glycoprotein.
With the aim of comparing bilayer partitioning with bulk-
phase partitioning, Wimley and White also established a
whole-residue hydrophobicity scale for partitioning into n-oc-
tanol [10^12]. The octanol scale provides a reasonable esti-
mate of the free energy of inserting K-helical amino acid res-
idues into bilayers, i.e. it results particularly suitable to
distinguish TMDs in hydropathy plots [22]. Thus we analyzed
in more detail the putative low-energy membrane organization
of the preTM/TMD region in Fig. 1B. Hydropathy was ini-
Fig. 1. A: Interfacial hydrophobicity of the surface Ebola GP pre-
cursor (Zaire strain, GenBank accession number: U31033). The plot
(mean values of free energies of transfer from membrane interfaces
to water for a window of 11 amino acids) was constructed using the
Wimley^White scale for individual residues [12]. Designated regions
include: SP, signal peptide; FP, fusion peptide; preTM, pre-trans-
membrane; TMD, transmembrane domain. B: Standard free ener-
gies of transfer (kcal mol31) from octanol (a) and interface (b) to
water for the preTM/TMD region of Ebola GP (residues 640^676,
i.e. last 37 residues). Plots represent for each center amino acid the
sum of free energies in windows of 11 residues. Interfacial values in-
clude conformational free energy contribution (see text for details).
Horizontal lines indicate the predicted locations for the transmem-
brane (tm) and interfacial helices (int).
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tially computed using the octanol-to-water partitioning free
energies (empty circles), i.e. positive values in the plot denote
tendency to remain in the octanol phase. The plot reveals the
existence of a stretch (int), close to the 0 equilibrium value,
which is followed by a region with a transmembrane tendency
(tm). Hydropathy was complementarily estimated as interfa-
cial partitioning. To make both partitioning processes compa-
rable, the conformational energy, approximately 30.41 kcal
mol31 per residue adopting an K-helical conformation [23],
must be added to the free energy of partitioning into interfa-
ces of the unfolded sequence (see [24] for detailed explana-
tions). In Fig. 1B we include a plot (¢lled symbols) which is
based on the membrane interface:water free energy of parti-
tioning, including conformational energy (i.e. positive values
in this case denote a tendency to remain interface-bound).
When compared to the octanol plot, the interfacial plot dis-
played more positive values within the ‘int’ segment, indicat-
ing the higher preference of this region for the interface. In
contrast, the ‘tm’ region displayed rather similar values in
both plots, a fact compatible with the theoretical existence
of the TMD stretch in equilibrium between the octanol and
membrane interface phases. In summary, hydropathy data in
Fig. 1 are consistent with the existence in the carboxy-end of
GP2 of an interfacial-transmembrane structural motif.
Membrane interaction of Ebola GP preTM was further
characterized with the hydrophobic-at-interface moment
(Fig. 2). This analysis revealed that the sequence would gen-
erate one face with a strong a⁄nity for membranes if folded
as an K-helix (Fig. 2A). Hydrophobic moments measure the
periodicity of residue distribution along the secondary struc-
ture elements [13,14]. Orienting hydrophobic residues prefer-
entially towards one face of the element has been proposed to
favor hydrophobic interactions between membranes and pro-
tein sequences. The moment, calculated as a function of the
angle between consecutive residues (N), displayed for GP
preTM a maximum at about N=100‡, indicating that adop-
tion of an K-helical conformation in solution optimizes the
residue distribution required for e¡ective partitioning into
membrane interfaces (Fig. 2A).
The hydrophobic moment plots with ¢xed N=100‡ corre-
sponding to GP preTM/TMD sequences derived from the
di¡erent Ebola subtypes and Marburg (Musoke strain) de-
tected a peak just preceding the transmembrane anchor
(Fig. 2B). The alignment of these carboxy-terminal GP se-
quences con¢rms a high degree of conservation of interfacial
Trp and Leu residues within the preTM region (data not
shown). Thus, the presence of an amphipathic interfacial helix
located at the membrane-proximal region of GP seems to be a
common structural motif among members belonging to the
Filoviridae family. Experimental evidence is provided below
suggesting that this GP structural element is able to sustain
an interaction with membranes.
3.2. GP preTM interactions with membranes
The membrane-interacting ability of EBOc, a peptide rep-
resenting the preTM of Ebola GP (Zaire strains), was initially
assessed. A scrambled sequence of the same region, EBOscr,
was designed as a negative control. This control sequence
displayed a hydrophobic-at-interface moment maximum
shifted to N=180‡ (see Fig. 2A), and therefore it was predicted
to adopt non-helical, amphipathic extended structures in con-
tact with membrane interfaces. EBOc and EBOscr penetration
into membranes was ¢rst studied by the monolayer technique
(Fig. 3A). We anticipated that, being predicted to be interfa-
cial sequences, these peptides might partition into lipid mono-
layers altering their surface pressure. The penetration capacity
depending on the lipid ¢lm initial pressure (Z0) was deter-
mined measuring the monolayer exclusion pressure (Zex),
i.e., the Z0 at which no increment in pressure (vZ=0) was
observed afer peptide injection into the subphase [17]. The
Zex values obtained from plots in Fig. 3A were 33.0 mN
m31 and 31.5 mN m31 for EBOc and EBOscr, respectively,
indicating a comparable capacity of both sequences to pene-
trate into membranes. Moreover, both values lie within the
range of lateral pressures expected in biological membranes
(Z0v 30^35 mN m31 [25]).
Fig. 3B,C shows data on the capacity of EBOc and EBOscr
to partition and insert into vesicle membranes. Spectra in Fig.
3B demonstrate that EBOc intrinsic £uorescence increased
and shifted the maximum emission wavelength (from 354 to
340 nm) in the presence of PC LUV. This is indicative of the
Trp residues sensing a low-polarity environment provided by
Fig. 2. A: Hydrophobic-at-interface moment of the 640^657 Ebola
GP (Zaire subtypes) segment (b) and a scrambled sequence (F), cal-
culated as a function of the N angle. B: Hydrophobic-at-interface
moments for a ¢xed N=100‡ corresponding to similar regions de-
rived from the di¡erent ¢loviruses indicated in the panels. Repre-
sented values are the sum of the moments in a window of length 11
amino acids, or approximately three helical turns.
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the bilayer. EBOscr intrinsic £uorescence also increased but
the position of the emission maximum did not change when
added to vesicles. A more signi¢cant di¡erence could be ob-
served when peptides were pre-incubated in solution before
vesicle addition. EBOc £uorescence again increased and
blue-shifted, indicating that pre-incubation in solution did
not a¡ect the partitioning equilibrium of this peptide. In con-
trast, EBOscr emission did not appreciably change upon addi-
tion of vesicles indicating that the peptide lost the capability
to partition into membranes under these conditions. It ap-
pears that e¡ective incorporation of EBOscr into membranes
could only be achieved under non-equilibrium conditions, i.e.
most likely before a competing self-aggregation process
evolved. This is further illustrated by the fractional change
in peptide intrinsic £uorescence upon titration with increasing
amounts of lipid vesicles (Fig. 3C). While EBOc Trp emission
increased and reached saturation, EBOscr £uorescence did not
change signi¢cantly. Thus, in contrast with the peptide repre-
senting the functional sequence, incubation of EBOscr in so-
lution led to self-aggregation, a possibility that was supported
by the IR experiments (see below).
IR data in Fig. 4 are consistent with di¡erent conforma-
tions being adopted by EBOc and EBOscr in solution and
associated to membranes. The conformation sensitive amide
I band of EBOc in deuterated bu¡er (Fig. 4A) showed a main
component at 1647 cm31. In this region the presence of un-
ordered structures has been described (V1643 cm31) together
with absorption by K-helical conformations (1641^1658 cm31)
[21]. In contrast, maximum absorption by the EBOscr peptide
was found at 1619 cm31, a band related to intermolecular
interaction of L-like extended conformations, such as those
found for amyloid-type aggregates. This is con¢rmed by the
simultaneous presence of a minor component at high-¢eld
(V1680 cm31) described for this type of extended structures.
The spectra in Fig. 4B were obtained in the presence of PC
LUV. In EBOc samples, within the amide I region appeared a
conspicuous band centered at 1647 cm31 which indicates that
the preferential structure adopted by the peptide in mem-
branes was also K-helical. To study the structure of EBOscr
in membranes, the peptide was added to vesicles already
present in solution. The spectrum of EBOscr associated to
membranes re£ects that lipids did not change the main con-
formation adopted by the peptide either, but in this case the
low-¢eld band was split into two sharper components centered
at 1629 and 1615 cm31. These bands may be assigned to
classical antiparallel L-sheets and intermolecularly H-bonded
aggregates of extended structure, respectively [21].
In summary, from the IR data above it may be deduced
that the sequence representing the functional pre-transmem-
brane region of Ebola GP adopts an K-helical conformation
both in solution and in membranes. Preservation of the hy-
drophobicity-at-interface distribution within this helical struc-
ture appears to be required for e⁄cient partitioning and fold-
ing into membranes. Thus, the preTM is not merely a cluster
of aromatic residues showing a tendency to interact with
membranes, but it also adopts an intrinsic structure that opti-
mizes partitioning into membrane interfaces.
These results may be further discussed in the context of
current understanding of the energetics of interfacial parti-
tioning [22,24]. The fraction of helical content of membrane-
bound EBOc was ca. 0.8 as estimated from IR data (Fig. 4B),
which corresponds to approximately 13^14 residues adopting
a de¢ned helical conformation. Thus, considering a per-resi-
due change of 30.41 kcal mol31 [23], the free energy change
upon peptide folding at interfaces (vGif ) would amount to
(35.3)^(35.7) kcal mol31. The partitioning isotherm dis-
played in Fig. 3C rendered an experimental Kx value of
2.2U105 for EBOc partitioning into PC LUV. Computation
of the maximum total free energy of partitioning
(vGt =3RTUln Kx) gives an estimate of ca. 37.3 kcal
Fig. 3. A: Penetration of EBOc (¢lled symbols) and EBOscr (empty
symbols) into PC monolayers. Maximum increase in surface pres-
sure induced upon injection of 0.23 WM peptide in the subphase
was measured as a function of the initial surface pressure of the
phospholipid monolayers. B: Fluorescence emission spectra of
EBOc and EBOscr. Solid lines: peptide in bu¡er; Discontinuous
lines: peptides added to PC LUV; Dotted lines: peptides pre-incu-
bated in solution (15 min) before addition of vesicles. Peptide con-
centration was 0.5 WM and, in vesicle samples, the peptide-to-lipid
mole ratio was 1:200. C: Partitioning curves as estimated from the
fractional change in Trp £uorescence in the presence of increasing
amounts of PC LUV. The solid lines correspond to the best ¢ttings
of the experimental values to a hyperbolic function. Symbols as in
panel A.
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mol31. In consequence, conformational free energy appears to
be the main contribution to EBOc interfacial partitioning.
Interfering with the ability of the Ebola preTM sequence to
fold correctly as an K-helix by redistributing interfacial resi-
dues, results in low membrane partitioning at equilibrium and
formation of intermolecularly H-bonded extended strands,
both in solution and at interfaces.
The experimental results in Table 1 summarize the e¡ects of
di¡erent lipid compositions on peptide bilayer penetration
and e¥ux. Comparable shifts of EBOc £uorescence emission
maximum towards shorter wavelengths could be detected in
the presence of vesicles made of di¡erent lipid compositions.
This fact con¢rms that penetration occurred in all the mix-
tures tested. However, leakage was barely detectable in
vesicles devoid of the raft-associated lipid SM [26^28]. The
presence of SM at increasing molar fractions promoted the
peptide permeabilizing e¡ect. Moreover, heating PC:SM mix-
tures above the transition temperature of SM (TcV39‡C) in-
hibited leakage induced by the peptide but not its penetration.
These observations are consistent with a SM e¡ect stemming
from its ability to laterally segregate into ordered lipid phases
[26^28]. It should be pointed out that e¥ux induced by EBOc
was not accompanied by vesicle aggregation or fusion (data
not shown). Thus membrane perturbations leading to the ob-
served permeabilization occurred within isolated vesicles.
The SM e¡ect seemed to not arise from an intrinsic insta-
bility of these vesicles, since the control EBOscr sequence
could not induce leakage at any tested dose even though it
interacted with liposomes (see lipid-induced structural changes
in EBOscr, Fig. 4). This result underscores the importance of
residue distribution within the preTM sequence for the induc-
tion of membrane perturbations. However, since EBOscr pep-
tide does not interact with membranes in a reproducible man-
ner under equilibrium conditions (Fig. 3), we used melittin as
a control to explore in more detail the speci¢c role of SM
(Fig. 5). Melittin, the main proteinaceous component of hon-
eybee venom, has been extensively studied as a model peptide
for lytic peptide^lipid interactions ([29^31], and references
therein). In particular, melittin has been shown to locate at
the interface of electrically neutral PC membranes as a helical
monomer [32] and induce dose-dependent permeabilization of
PC vesicles [29^31]. In agreement with previously reported
data [29], melittin-induced e¥ux of PC vesicle contents was
already observed at a peptide-to-lipid mole ratio of 1:1000,
while maximum permeabilization levels were attained at 1:100
(Fig. 5A). Unexpectedly, inclusion of 50 mol% SM into the
lipid vesicle composition decreased these peptide-to-lipid mole
ratios by an order of magnitude. Although EBOc required
higher peptide-to-lipid mole ratios than melittin to induce
Fig. 4. Infrared spectra of EBOc and EBOscr, in the amide I region. A: IR spectra in D2O bu¡er. B: IR spectra of peptides associated to PC
vesicles. Peptide and vesicles were incubated at a peptide-to-lipid ratio of 1:20, peptide bound to vesicles was subsequently isolated by £otation
in D2O bu¡er as previously described [20]. Right-hand panels correspond to Fourier-deconvolved spectra.
Table 1
Interactions of EBOc with model membranes. In£uence of lipid
composition on intrinsic £uorescence and induction of leakage
vV (nm)a Leakage (%)b
PC 314 10
PCc 0 6 5
PCd 318 12
PC:SM (2:1) 313 38
PC:SM (1:1) 313 83
PC:SM (1:1)c 0 6 5
PC:SM (1:1)d 318 98
PC:SM (2:1) T=50‡C 310 8
PC:SM (1:1) T=50‡C 310 6 5
PC:CHOL (2:1) 310 8
PC:CHOL (1:1) nd 6 5
PC:SM:CHOL (1:1:1) 310 20
PC:PE:SM:CHOL (1:1:1:1.5) 39 6 5
aIncrease in Trp maximum emission wavelenght. Maximum emission
wavelength of the peptides (0.5 WM) in bu¡er was 354 nm. Peptide-
to-lipid ratio was 1:200.
bPercentage of leakage measured at time= 30 min. The peptide-to-
lipid mole ratio was 1:20 and the lipid concentration 100 WM.
cMeasurements were carried out using the EBOscr control sequence.
dMeasurements were carried out using melittin as a control. Leak-
age was measured at a peptide-to-lipid mole ratio of 1:1000.
FEBS 26840 19-12-02
A. Sa¤ez-Cirio¤n et al./FEBS Letters 533 (2003) 47^53 51
leakage of vesicles (Fig. 5B), the stimulatory e¡ect of the SM
lipid seemed to be similar to that observed for melittin. As for
the case of EBOc, we observed comparable shifts in £uores-
cence emission maximum of melittin Trp towards shorter
wavelengths with increasing amounts of PC and PC:SM
(1:1) vesicles (see Table 1), a fact consistent with a similar
degree of association to both membranes. To our knowledge
this stimulatory e¡ect of SM on the capacity of melittin to
permeabilize vesicles was not previously described. We note
here that melittin permeabilized SM-containing vesicles at
peptide-to-lipid mole ratios, i.e. 1:10 000, far below those re-
quired for induction of macroscopic changes (disc formation)
which occur at peptide-to-lipid mole ratios as high as 1:10
[33].
3.3. Concluding remarks
Our study combining a new predictive tool with experimen-
tal veri¢cation suggests that the preTM sequence of Ebola GP
is a membrane-partitioning helical domain with an ability to
perturb the integrity of SM-containing phospholipid bilayers.
Thus, the preTM sequence would immerse into the SM-rich
viral membrane milieu that seems to be inherently more prone
to destabilization by a membrane-disrupting toxic peptide
such as melittin. One can speculate that lipid modulation of
the ability to break down the membrane permeability barrier
is a common adaptive mechanism among sequences of diverse
origin. Melittin shows high hemolytic activity and membrane
speci¢city for zwitterionic phospholipids in vesicle leakage as-
says [29^31]. SM is abundant at the external monolayer of the
erythrocyte and other cell plasma membranes, therefore it
would be a good candidate to modulate the toxic action of
melittin. Ebola GP preTM sequence might use similar mech-
anisms to damage the membrane organization of the viral
envelope.
Thus, the preTM may constitute a functional element of
Ebola GP implied in the promotion of the membrane desta-
bilization required for fusion. It has been hypothesized that
the helical core structure of GP2 subunit would bring the two
hydrophobic regions not appearing in the crystal, FP and
preTM/TMD, to close spatial proximity [3,4]. The GP2
preTM sequence might in this way play an active role in
perturbing apposed membranes during fusion. Detection and
characterization of functional sequences within the fusion me-
diator GP are crucial since they might become in the future
putative targets for speci¢c anti-Ebola therapeutics. We have
recently shown that an equivalent preTM region in fusogenic
gp41 HIV-1 associates with raft-type lipids and induces mem-
brane perturbations [34]. This HIV-1 region seems to be rec-
ognized by anti-gp41 broadly neutralizing monoclonal anti-
bodies and has been proposed to represent an important
focus for clinical intervention [35]. In this sense, the Ebola
GP preTM might also represent an attractive focus for the
development of antiviral strategies.
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